Kidney disease among patients with sickle cell disease, hemoglobin SS and SC

Clinical Journal of the American Society of Nephrology

Volumn 11, Issue 2, 2016, Pages 207-215

  Drawz, Paul ^a   Ayyappan, Sabarish ^b   Nouraie, Mehdi ^c   Saraf, Santosh ^e   Gordeuk, Victor ^d   Hostetter, Thomas ^b   Gladwin, Mark T ^f   Little, Jane ^b  

^a UNIVERSITY OF MINNESOTA   (United States)

^b UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

^c HOWARD UNIVERSITY   (United States)

^d Comprehensive Sickle Cell Center ^*  (United States)

^e UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^f UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Acidosis; Albuminuria; Anemia, sickle cell; Blood pressure; Chronic kidney disease; Glomerular filtration rate; Humans; Hydroxyurea; Hypertension, pulmonary

Indexed keywords

ALKALINE PHOSPHATASE; BICARBONATE; BILIRUBIN; ERYTHROPOIETIN; FERRITIN; HYDROXYUREA; LACTATE DEHYDROGENASE; PHOSPHORUS; POTASSIUM; SILDENAFIL; BIOLOGICAL MARKER; HEMOGLOBIN C; HEMOGLOBIN S;

6 MINUTE WALK TEST; ADULT; AGE DISTRIBUTION; ARTICLE; CARDIOVASCULAR PARAMETERS; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; EXERCISE TEST; FEMALE; GLOMERULUS FILTRATION RATE; HEMOGLOBIN SC DISEASE; HEMOLYSIS; HUMAN; KIDNEY DISEASE; KIDNEY TUBULE FUNCTION; MACROALBUMINURIA; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; MIDDLE AGED; MORBIDITY; MORTALITY; MULTICENTER STUDY; PROTEINURIA; PULMONARY HYPERTENSION; RETICULOCYTE COUNT; SICKLE CELL ANEMIA; SYSTOLIC BLOOD PRESSURE; TRICUSPID REGURGITANT JET VELOCITY; ACID BASE BALANCE; ALBUMINURIA; ANEMIA, SICKLE CELL; BLOOD; CLINICAL TRIAL (TOPIC); COMPARATIVE STUDY; KIDNEY; KIDNEY DISEASES; METABOLISM; MULTICENTER STUDY (TOPIC); NORTH AMERICA; OBSERVATIONAL STUDY; PATHOPHYSIOLOGY; PHENOTYPE; PREVALENCE; RISK FACTOR; UNITED KINGDOM;

ACID-BASE EQUILIBRIUM; ADULT; ALBUMINURIA; ANEMIA, SICKLE CELL; BIOMARKERS; CLINICAL TRIALS AS TOPIC; FEMALE; GLOMERULAR FILTRATION RATE; HEMOGLOBIN C; HEMOGLOBIN SC DISEASE; HEMOGLOBIN, SICKLE; HISTORICALLY CONTROLLED STUDY; HUMANS; KIDNEY; KIDNEY DISEASES; MALE; MIDDLE AGED; MULTICENTER STUDIES AS TOPIC; NORTH AMERICA; OBSERVATIONAL STUDIES AS TOPIC; PHENOTYPE; PREVALENCE; RISK FACTORS; UNITED KINGDOM;

EID: 84957048357     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.03940415     Document Type: Article

References (37)

1. Baum KF, Dunn DT, MaudeGH, Serjeant GR: The painful crisis of homozygous sickle cell disease. A study of the risk factors. Arch Intern Med 147: 1231-1234, 1987.
2. Ohene-Frempong K,Weiner SJ, Sleeper LA, Miller ST, Embury S, Moohr JW, Wethers DL, Pegelow CH, Gill FM: Cerebrovascular accidents in sickle cell disease: Rates and risk factors. Blood 91:288-294, 1998.
3. Platt OS, Thorington BD, Brambilla DJ, Milner PF, Rosse WF, Vichinsky E, Kinney TR: Pain in sickle cell disease. Rates and risk factors. N Engl J Med 325: 11-16, 1991.
4. Powars DR, Chan LS, Hiti A, Ramicone E, Johnson C: Outcome of sickle cell anemia: A 4-decade observational study of 1056 patients. Medicine (Baltimore) 84: 363-376, 2005.
5. Powars DR, Hiti A, Ramicone E, Johnson C, Chan L: Outcome in hemoglobin SC disease: A four-decade observational study of clinical, hematologic, and genetic factors. Am J Hematol 70: 206-215, 2002.
6. Nagel RL, Fabry ME, Steinberg MH: The paradox of hemoglobin SC disease. Blood Rev 17: 167-178, 2003.
7. Thomas AN, Pattison C, Serjeant GR: Causes of death in sickle-cell disease in Jamaica. Br Med J (Clin Res Ed) 285: 633-635, 1982.
8. Sharpe CC, Thein SL: How I treat renal complications in sickle cell disease. Blood 123: 3720-3726, 2014.
9. Diskin CJ, Stokes TJ, Dansby LM, Radcliff L, Carter TB: Can acidosis and hyperphosphataemia result in increased erythropoietin dosing in haemodialysis patients? Nephrology (Carlton) 11: 394-399, 2006.
10. Ataga KI, Orringer EP: Renal abnormalities in sickle cell disease. Am J Hematol 63: 205-211, 2000.
11. Batlle D, Itsarayoungyuen K, Arruda JA, Kurtzman NA: Hyperkalemic hyperchloremic metabolic acidosis in sickle cell hemoglobinopathies. Am J Med 72: 188-192, 1982.
12. Guasch A, Cua M, Mitch WE: Early detection and the course of glomerular injury in patients with sickle cell anemia. Kidney Int 49: 786-791, 1996.
13. SteinbergMH, Barton F, CastroO, Pegelow CH, Ballas SK, Kutlar A, Orringer E, Bellevue R, Olivieri N, Eckman J, VarmaM, Ramirez G, Adler B, SmithW, Carlos T, Ataga K, DeCastro L, Bigelow C, Saunthararajah Y, Telfer M, Vichinsky E, Claster S, Shurin S, Bridges K,Waclawiw M, Bonds D, Terrin M: Effect of hydroxyurea on mortality and morbidity in adult sickle cell anemia: Risks and benefits up to 9 years of treatment. JAMA 289: 1645-1651, 2003.
14. Maurel S, Stankovic Stojanovic K, Avellino V, Girshovich A, Letavernier E, GrateauG, Baud L, Girot R, Lionnet F,Haymann JP: Prevalence and correlates of metabolic acidosis among patients with homozygous sickle cell disease. Clin J Am Soc Nephrol 9:648-653, 2014.
15. Saraf SL, Zhang X, Kanias T, Lash JP, Molokie RE, Oza B, Lai C, Rowe JH, Gowhari M, Hassan J, Desimone J, Machado RF, Gladwin MT, Little JA, Gordeuk VR: Haemoglobinuria is associated with chronic kidney disease and its progression in patients with sickle cell anaemia. Br J Haematol 164: 729-739, 2014.
16. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D; Modification of Diet in Renal Disease Study Group: A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation. Ann Intern Med 130:461-470, 1999.
17. Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF 3rd, Feldman HI, Kusek JW, Eggers P, Van Lente F, Greene T, Coresh J; CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration): A new equation to estimate glomerular filtration rate. Ann Intern Med 150: 604-612, 2009.
18. Arlet JB, Ribeil JA, Chatellier G, Eladari D, De Seigneux S, Souberbielle JC, Friedlander G, de Montalembert M, Pouchot J, Prié D, Courbebaisse M: Determination of the best method to estimate glomerular filtration rate from serum creatinine in adult patients with sickle cell disease: A prospective observational cohort study. BMC Nephrol 13: 83, 2012.
19. Rule AD, Gussak HM, Pond GR, Bergstralh EJ, StegallMD, Cosio FG, Larson TS: Measured and estimated GFR in healthy potential kidney donors. Am J Kidney Dis 43: 112-119, 2004.
20. Shah SN, Abramowitz M, Hostetter TH, Melamed ML: Serum bicarbonate levels and the progression of kidney disease: A cohort study. Am J Kidney Dis 54: 270-277, 2009.
21. Sharpe CC, Thein SL: Sickle cell nephropathy - a practical approach. Br J Haematol 155: 287-297, 2011.
22. Asnani MR, Reid ME: Renal function in adult Jamaicans with homozygous sickle cell disease. Hematology 20: 422-428, 2015.
23. Miller JA, Curtis JR, Sochett EB: Relationship between diurnal blood pressure, renal hemodynamic function, and the reninangiotensin system in type 1 diabetes. Diabetes 52: 1806-1811,2003.
24. Thompson J, Reid M,Hambleton I, Serjeant GR: Albuminuria and renal function in homozygous sickle cell disease: Observations from a cohort study. Arch Intern Med 167: 701-708, 2007.
25. Desai PC, Deal AM, Brittain JE, Jones S, Hinderliter A, Ataga KI: Decades after the cooperative study: A re-examination of systemic blood pressure in sickle cell disease. Am J Hematol 87: E65-E68, 2012.
26. Kaul DK, Zhang X, Dasgupta T, Fabry ME: Arginine therapy of transgenic-knockout sickle mice improves microvascular function by reducing non-nitric oxide vasodilators, hemolysis, and oxidative stress. Am J Physiol Heart Circ Physiol 295: H39-H47,2008.
27. Lamarre Y, Hardy-Dessources MD, Romana M, Lalanne-Mistrih ML,Waltz X, Petras M, Doumdo L, Blanchet-Deverly A, Martino J, Tressières B, Maillard F, Tarer V, Etienne-Julan M, Connes P: Relationships between systemic vascular resistance, blood rheology and nitric oxide in childrenwith sickle cell anemia or sickle cell-hemoglobin C disease. Clin Hemorheol Microcirc 58: 307-316, 2014.
28. Itano HA, Keitel HG, Thompson D: Hyposthenuria in sickle cell anemia: A reversible renal defect. J Clin Invest 35: 998-1007,1956.
29. Cochran RT Jr.: Hyposthenuria in sickle cell states. Arch Intern Med 112: 222-225, 1963.
30. Novelli EM, Hildesheim M, Rosano C, Vanderpool R, Simon M, Kato GJ, Gladwin MT: Elevated pulse pressure is associated with hemolysis, proteinuria and chronic kidney disease in sickle cell disease. PLoS One 9: e114309, 2014.
31. Gordeuk VR, Sachdev V, Taylor JG, Gladwin MT, Kato G, Castro OL: Relative systemic hypertension in patients with sickle cell disease is associated with risk of pulmonary hypertension and renal insufficiency. Am J Hematol 83: 15-18, 2008.
32. Pegelow CH, Colangelo L, Steinberg M, Wright EC, Smith J, Phillips G, Vichinsky E:Natural history of blood pressure in sickle cell disease: Risks for stroke and death associated with relative hypertension in sickle cell anemia. Am J Med 102: 171-177,1997.
33. Scheinman JI: Sickle cell disease and the kidney. Semin Nephrol 23: 66-76, 2003.
34. Ueda Y, Nagel RL, Bookchin RM: An increased Bohr effect in sickle cell anemia. Blood 53: 472-480, 1979.
35. Ueda Y, Bookchin RM: Effects of carbon dioxide and pH variations in vitro on blood respiratory functions, red blood cell volume, transmembrane pH gradients, and sickling in sickle cell anemia. J Lab Clin Med 104: 146-159, 1984.
36. Statius van Eps LW, Schouten H, Haar Romeny-Wachter CC, La Porte-Wijsman LW: The relation between age and renal concentrating capacity in sickle cell disease and hemoglobin C disease. Clin Chim Acta 27: 501-511, 1970.
37. GladwinMT, Vichinsky E: Pulmonary complications of sickle cell disease. N Engl J Med 359: 2254-2265, 2008.